Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials
Crossref DOI link: https://doi.org/10.1007/s12325-016-0326-5
Published Online: 2016-04-12
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Herrmann, Kathrin
Brunell, Steven C.
Li, Yan
Zhou, Ming
Maggs, David G.
Funding for this research was provided by:
AstraZeneca